Virus susceptibility of Chinese hamster ovary (CHO) cells and detection of viral contaminations by adventitious agent testing
Authors:
Open Access
- 26 March 2010
- journal article
- research article
- Published by Wiley in Biotechnology and Bioengineering
- Vol. 106 (4) , 598-607
Abstract
Biopharmaceuticals are of increasing importance in the treatment of a variety of diseases. A remaining concern associated with their production is the potential introduction of adventitious agents into their manufacturing process, which may compromise the pathogen safety of a product and potentially cause stock‐out situations for important medical supplies. To ensure the safety of biological therapeutics, regulatory guidance requires adventitious agent testing (AAT) of the bulk harvest. AAT is a deliberately promiscuous assay procedure which has been developed to indicate, ideally, the presence of any viral contaminant. One of the most important cell lines used in the production of biopharmaceuticals is Chinese hamster ovary (CHO) cells and while viral infections of CHO cells have occurred, a systematic screen of their virus susceptibility has never been published. We investigated the susceptibility of CHO cells to infection by 14 different viruses, including members of 12 families and representatives or the very species that were implicated in previously reported production cell infections. Based on our results, four different infection outcomes were distinguished, based on the possible combinations of the two factors (i) the induction, or not, of a cytopathic effect and (ii) the ability, or not, to replicate in CHO cells. Our results demonstrate that the current AAT is effective for the detection of viruses which are able to replicate in CHO cells. Due to the restricted virus susceptibility of CHO cells and the routine AAT of bulk harvests, our results provide re‐assurance for the very high safety margins of CHO cell‐derived biopharmaceuticals. Biotechnol. Bioeng. 2010;106: 598–607.Keywords
This publication has 67 references indexed in Scilit:
- Emerging trends in plasma‐free manufacturing of recombinant protein therapeutics expressed in mammalian cellsBiotechnology Journal, 2009
- Theiler's Virus-Induced Intrinsic Apoptosis in M1-D Macrophages Is Bax Mediated and Restricts Virus Infectivity: a Mechanism for Persistence of a Cytolytic VirusJournal of Virology, 2008
- Novel vectors expressing anti-apoptotic protein Bcl-2 to study cell death in Semliki Forest virus-infected cellsVirus Research, 2008
- Inhibition of Foot-and-Mouth Disease Virus Infections in Cell Cultures with Antisense Morpholino OligomersJournal of Virology, 2007
- Genetic and Phenotypic Variation of Foot-and-Mouth Disease Virus during Serial Passages in a Natural HostJournal of Virology, 2007
- A mouse cell-adapted NS4B mutation attenuates West Nile virus RNA synthesisVirology, 2007
- Theiler's Murine Encephalomyelitis Virus Leader Protein Amino Acid Residue 57 Regulates Subgroup-Specific Virus Growth on BHK-21 CellsJournal of Virology, 2006
- Murine gammaherpesvirus-68 glycoprotein B presents a difficult neutralization target to monoclonal antibodies derived from infected miceJournal of General Virology, 2006
- N- and 6-O-Sulfated Heparan Sulfates Mediate Internalization of Coxsackievirus B3 Variant PD into CHO-K1 CellsJournal of Virology, 2006
- Production of recombinant protein therapeutics in cultivated mammalian cellsNature Biotechnology, 2004